AI in Operating Room Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Hardware, Software-as-a-Service (SaaS)), By Technology (Machine Learning, Deep Learning, Natural Language Processing (NLP), Others), By Indication (Cardiology, Orthopedics, Urology, Gastroenterology, Neurology, Others), By Application (Training, Diagnosis, Surgical Planning & Rehabilitation, Outcomes & Risk Analysis, Integration & Connectivity, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F

Market Overview

The Global AI in Operating Room Market was valued at USD 221.74 million in 2024 and is expected to reach USD 1748.91 million by 2030 with a CAGR of 41.09% during the forecast period. The global market for AI in Operating Room is experiencing significant growth, driven by increasing prevalence of fatal chronic diseases, rising adoption of advanced technology, and increase in number of surgeries conducted are driving the growth of market, globally. Operating room is a facility where surgical interventions and procedures are done to treat patients from various physiological and pathological conditions. It is safe, sterile environment, and inert room to perform surgeries. The other factors supporting the market's growth are rising investments by governments, increasing initiatives by key players, rise in geriatric population, rise in patients’ preference for minimally invasive surgeries, large number of patient pool, presence of better healthcare services. Also, increasing mergers, partnerships, and acquisitions among the market participants are fueling the growth of the market.

Key Market Drivers

Rising Surgical Volume & Pressure to Improve Outcomes

Global surgical demand is large and rising, and health systems face intense pressure to improve safety, efficiency and outcomes — conditions that favor AI tools in the operating room. The Lancet Commission on Global Surgery and WHO surgical indicators emphasize that safe, timely surgical care is central to health system performance; surgical volume per 100,000 population is a key metric tracked by governments and international bodies. As populations age and noncommunicable diseases increase, the absolute number of operations (elective and emergency) grows; the World Bank compiles surgical-procedure rates per 100,000 population derived from the Lancet Commission. This increasing caseload puts strain on hospital capacity, staffing, and perioperative pathways, creating demand for technologies that can make surgical teams more productive, reduce complications, and speed throughput.

AI in the OR addresses several practical capacity and safety issues: intraoperative decision support (real-time image interpretation, anatomy segmentation), workflow orchestration (predicting case durations and resource needs), automated documentation, and early detection of physiological deterioration. Governments and payers are sensitive to metrics like complication rates, length of stay, and readmissions; AI tools that demonstrably reduce these are attractive for adoption and scale. Public reporting and regulatory measurement frameworks mean hospitals have tangible incentives to invest in technologies that improve adherence to clinical protocols and reduce variability.

Public Funding, Regulatory Clarity and Technology Roadmaps

A robust driver for AI in the OR is the combination of targeted public funding, clearer regulatory frameworks for AI devices, and government innovation programs that explicitly back AI/robotics in healthcare. National research agencies and interagency programs (e.g., NSF solicitations that include smart health/AI topics, NIH/NIBIB robotics grants) are investing in translational projects that move surgical AI and robotic assistance from lab prototypes into clinical pilots. These public grants reduce translational risk for hospitals and vendors and often include expectations for clinical validation and data-sharing that accelerate evidence generation.

On the regulatory side, agencies such as the U.S. Food and Drug Administration (FDA) have published guidance and resources for AI/Machine-Learning-enabled Software as a Medical Device (SaMD), including an AI-Enabled Medical Device List and lifecycle guidance for AI/ML tools. That regulatory attention—while demanding—creates a predictable pathway for market entry and iterative updates. Parallel programs from payers and innovation centers (e.g., CMS AI challenges, CMS explorations into AI-enabled coverage models) signal an interest in assessing value and reimbursement mechanisms for AI solutions that demonstrably improve outcomes for Medicare/Medicaid populations.

Download Free Sample Report

Key Market Challenges

Regulatory & Evidence Barriers for High-Risk, Real-Time OR AI

Despite clearer guidances, regulatory and evidentiary requirements remain a major barrier for AI intended for real-time intraoperative use. The OR is a high-risk environment: software that influences surgical decisions or robotic motion can alter patient safety directly. Regulators (e.g., FDA) classify such products stringently and expect robust clinical evidence for safety, accuracy, and robustness — including validation across devices, patient populations, and imaging/lighting conditions. For adaptive AI (models that learn or update over time), regulators require lifecycle plans, change-control processes, and post-market monitoring strategies; meeting those expectations requires substantial technical and clinical resources.

Generating the necessary evidence is costly and slow. Randomized or carefully controlled prospective trials, multi-site validation and long-tail safety surveillance are expensive, and surgical workflows vary widely between hospitals and regions — complicating generalizability. Moreover, high-stakes OR AI tools must demonstrate resilience to edge cases, adversarial inputs (noisy signals), and integration risks (latencies, interoperability with OR systems, failover modes). For start-ups and smaller vendors, the combined cost of clinical trials, registration submissions, and post-market real-world data collection can be prohibitive.

Reimbursement, Procurement & Workflow Integration

Even when AI in the OR is technically ready and regulatory cleared, widespread adoption depends on reimbursement, procurement priorities, and smooth integration into clinical workflows. Payers historically have been cautious about reimbursing device-enabled software separately; while CMS has begun to test and reimburse certain AI tools and ran AI innovation challenges, reimbursement models for intraoperative AI (per-use fees, bundled payments, value-based contracts) remain immature. Academic analyses highlight that reimbursement policy can either spur rapid uptake or stifle use if economic incentives are misaligned.

Hospitals and surgical centers operate on tight budgets and complex procurement cycles: capital expenditure committees, clinical engineering signoffs, IT security reviews, and training plans are all required before deployment. AI tools that require workflow changes (e.g., mandatory image capture steps, new sensors or OR layouts) encounter resistance unless they clearly reduce costs, shorten case times, or improve outcomes in measurable ways. Integration complexity is real — connecting AI modules to existing imaging systems, EHRs, robotics controllers and OR networks require interoperability engineering, cybersecurity reviews, and often local customization.

Key Market Trends

AI-Enhanced Robotics & Intraoperative Assistance

One of the most visible trends is the convergence of AI with surgical robotics and image guidance to automate or augment intraoperative tasks. Governments and public research institutes are funding projects that enable robotic systems to perform precise subtasks (suturing, tissue retraction, fine dissection) under human supervision, or to provide real-time recommendations based on intraoperative imaging. NIH/NIBIB-funded robotics projects and other federally supported programs demonstrate a pipeline of translational research moving toward certified products. Industry and academic teams increasingly report algorithmic advances in instrument tracking, tissue characterization, and robotic control that can reduce surgeon fatigue, improve precision and standardize skill across practitioners.

From a policy perspective, regulators are creating pathways for AI components of robotic systems (SaMD, software updates, post-market surveillance), and agencies have issued nonbinding lists and guidance to foster transparency about AI devices authorized for marketing. Clinically, AI-assisted robotics promises shorter operative times, fewer complications, and improved reproducibility of complex procedures — all outcomes that health systems track and prize. As evidence accumulates from public-sector trials and funded demonstrations, the combination of robotics + AI is likely to be one of the fastest-adopted classes of intraoperative innovation.

OR Digitalization, Workflow AI & Remote Collaboration

Beyond task automation, a major trend is digitalizing the OR and embedding AI into workflow orchestration, predictive scheduling, and remote collaboration tools. AI models that predict case duration, blood-loss risk, or PACU need help hospitals optimize OR utilization and staff allocation. Digital OR platforms capture multi-modal data (video, device telemetry, vitals) and apply analytics to reduce turnover time, flag anomalies, and standardize checklists. Governments and payers are attentive to such efficiency gains because they translate into system-level savings and improved access to surgery.

Tele-mentoring and remote proctoring are also gaining traction: AI can enhance remote visualization, provide automated second-opinions, or prioritize cases for remote expert review. CMS’s expanding telehealth policies and pilot programs reflect a broader regulatory openness to remote care models; hospitals are exploring how remote proctoring with AI assistance can extend specialist reach into underserved regions. Politically and operationally, these capabilities align with healthcare access goals and workforce augmentation strategies that many governments pursue—enabling concentration of scarce surgical expertise without requiring patient travel.

Segmental Insights

Technology Insights

Based on Technology, Machine Learning holds the largest market share in the Global AI in Operating Room Market. Machine learning’s dominance is driven by its ability to analyze vast volumes of surgical data in real-time, enhance decision-making, and improve patient outcomes. It is widely applied in preoperative planning, intraoperative guidance, and postoperative analysis. Hospitals increasingly rely on ML-powered systems to predict surgical risks, optimize operating room schedules, and automate certain surgical tasks.

According to the U.S. Food and Drug Administration (FDA), over 500 AI and machine learning-enabled medical devices have been approved for use in healthcare as of 2024, with a large portion focused on surgical and imaging applications. Similarly, the European Commission’s eHealth Action Plan emphasizes the role of machine learning in improving surgical efficiency and reducing human errors. Machine learning also benefits from its flexibility—integrating with surgical robotics, imaging tools, and hospital management systems, which has made it the go-to technology for AI adoption in operating rooms. Its predictive analytics capability helps reduce surgery time and complications, leading to better patient safety and lower costs.

Download Free Sample Report

Regional Insights

Based on the region, North America holds the largest share of the global AI in operating room market, driven by its advanced healthcare infrastructure, high adoption of digital health technologies, and significant government investment in AI-driven medical innovations. The United States has been at the forefront of integrating AI into surgical practices, supported by initiatives from agencies such as the U.S. Food and Drug Administration (FDA), which has approved numerous AI-based surgical assistance tools in recent years. According to the Centers for Medicare & Medicaid Services (CMS), U.S. national healthcare expenditure reached USD 4.5 trillion in 2022, representing 17.3% of GDP, creating a robust environment for the adoption of advanced technologies such as AI-assisted robotic surgery and predictive analytics for surgical outcomes. Additionally, the National Institutes of Health (NIH) has been funding AI-related surgical research, including precision surgery projects, which accelerate innovation and market growth.

Canada also contributes significantly to the regional market leadership. The Canadian Institutes of Health Research (CIHR) has supported multiple AI in surgery programs, particularly in minimally invasive procedures and decision support systems for operating rooms. This has led to increased integration of AI technologies in hospitals across provinces like Ontario and British Columbia.

Recent Developments

• In July 2025, surgeons in the VCU Health Hume-Lee Transplant Center performed a surgery of living donor liver transplant fully with robotic assistance in early 2025, and they were the first surgeons in the country to perform such an intricate operation successfully.
• In July 2025, the leading surgical intelligence company, Proprio, is planning to build the first foundational AI model for surgery by integrating multimodal data. The company joined forces with the AWS partner network.
• In April 2024, Medtronic announced the introduction of 14 new AI-driven algorithms across surgical workflow, instrument, and anatomy detection to the Touch Surgery Performance Insights platform.
• In March 2024, Johnson & Johnson MedTech announced it is working to accelerate and scale artificial intelligence (AI) for surgery with NVIDIA, supporting increased access to real-time analysis and global availability of AI algorithms for surgical decision-making, education, and collaboration across the connected operating room.

Key Market Players

• Activ Surgical, Inc.
• Brainomix Ltd
• Caresyntax, Inc.
• DeepOR S.A.S
• ExplORer Surgical Corp.
• Holo Surgical Inc.
• LeanTaaS Inc.
• Medtronic Plc
• Scalpel Limited
• Theator Inc.

Report Scope:

In this report, Global AI in Operating Room Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• AI in Operating Room Market, By Component:

o   Hardware

o   Software-as-a-Service (SaaS)

• AI in Operating Room Market, By Technology:

o   Machine Learning

o   Deep Learning

o   Natural Language Processing (NLP)

o   Others

• AI in Operating Room Market, By Indication:

o   Cardiology

o   Orthopedics

o   Urology

o   Gastroenterology

o   Neurology

o   Others

• AI in Operating Room Market, By Application:

o   Training

o   Diagnosis

o   Surgical Planning & Rehabilitation

o   Outcomes & Risk Analysis

o   Integration & Connectivity

o   Others

• AI in Operating Room Market, By End User:

o   Hospitals

o   Ambulatory Surgical Centers

o   Others

• AI in Operating Room Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global AI in Operating Room Market.

Available Customizations:

Global AI in Operating Room Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global AI in Operating Room Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]